Biography
David Barrett joined Kite as the VP of Cell Biology in September 2022 where he serves as the lead of TranslationalMedicine and the Santa Monica and Philadelphia based research teams. He received a Masters in BiomedicalEngineering, as well as a combined MDPhD from Virginia Commonwealth University in 2004.He went on to complete a Pediatrics Residency and Fellowship in HematologyOncology at the Childrens Hospitalof Philadelphia in 2010 before starting his own lab as a physician scientist. During his time in the Cellular Therapyand Transplant Section at CHOP, he worked on the preclinical models for the cell therapy product that becameknown as Kymriah. Dr. Barrett cared for CAR T cell patients at CHOP from 2012-2020 and ran his lab investigatingtranslational science on CAR T trials, resulting in observations about cytokine release syndrome and the role ofmacrophages, the nature of antigen escape and the importance of juvenile cells in the pheresis and infusion products.In 2020 he left academics and joined Tmunity Therapeutics where he oversaw preclinical development andtranslational science on the solid tumor CAR T cell programs.